Published in Arch Intern Med on June 01, 1986
Role of the sar locus of Staphylococcus aureus in induction of endocarditis in rabbits. Infect Immun (1994) 1.92
Influence of Staphylococcus aureus antibody on experimental endocarditis in rabbits. Infect Immun (1987) 1.35
Protective efficacy of protein A-specific antibody against bacteremic infection due to Staphylococcus aureus in an infant rat model. Infect Immun (1989) 1.14
Comparative efficacies of liposomal amikacin (MiKasome) plus oxacillin versus conventional amikacin plus oxacillin in experimental endocarditis induced by Staphylococcus aureus: microbiological and echocardiographic analyses. Antimicrob Agents Chemother (1999) 1.12
Comparison of clinical and morphological characteristics of Staphylococcus aureus endocarditis with endocarditis caused by other pathogens. Heart (2005) 1.04
Complicating infectious foci in patients with Staphylococcus aureus or Streptococcus species bacteraemia. Eur J Clin Microbiol Infect Dis (2007) 0.93
Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study. Antimicrob Agents Chemother (2012) 0.89
A comparison of clinical features and mortality among methicillin-resistant and methicillin-sensitive strains of Staphylococcus aureus endocarditis. Yonsei Med J (2005) 0.86
Efficacy of ceftriaxone and gentamicin given once a day by using human-like pharmacokinetics in treatment of experimental staphylococcal endocarditis. Antimicrob Agents Chemother (2002) 0.83
Complicated community-acquired Staphylococcus endocarditis and multiple lung abscesses: case report and review of literature. Case Rep Infect Dis (2011) 0.76
Endocarditis in intravenous drug abusers with staphylococcal septicaemia. Br Heart J (1989) 0.75
Transient intestinal carriage after ingestion of antibiotic-resistant Enterococcus faecium from chicken and pork. N Engl J Med (2001) 2.38
Isolation of a fibronectin-binding protein from Staphylococcus aureus. Infect Immun (1982) 2.02
Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Thorax (1992) 1.97
Presence of erm gene classes in gram-positive bacteria of animal and human origin in Denmark. FEMS Microbiol Lett (1999) 1.93
Cross-reactions between Legionella pneumophila (serogroup 1) and twenty-eight other bacterial species, including other members of the family Legionellaceae. Infect Immun (1983) 1.93
Evaluation of a cefoxitin 30 microg disc on Iso-Sensitest agar for detection of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (2003) 1.91
Crossed immunoelectrophoretic analysis of Legionella pneumophila serogroup 1 antigens. Infect Immun (1983) 1.89
Experimental infection with Streptococcus pneumoniae in mice: correlation of in vitro activity and pharmacokinetic parameters with in vivo effect for 14 cephalosporins. J Infect Dis (1986) 1.84
Infections with the unusual human pathogens Agrobacterium species and Ochrobactrum anthropi. Clin Infect Dis (1994) 1.83
Increasing frequency of vertebral osteomyelitis following Staphylococcus aureus bacteraemia in Denmark 1980-1990. J Infect (1997) 1.79
Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies. Antimicrob Agents Chemother (2000) 1.76
Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Epidemiol Infect (1995) 1.63
Dicloxacillin and flucloxacillin: pharmacokinetics, protein binding and serum bactericidal titers in healthy subjects after oral administration. Infection (1995) 1.61
Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect (2007) 1.61
Clinical manifestations and molecular epidemiology of Vibrio vulnificus infections in Denmark. Eur J Clin Microbiol Infect Dis (1996) 1.59
Are variable repeats in the spa gene suitable targets for epidemiological studies of methicillin-resistant Staphylococcus aureus strains? Eur J Clin Microbiol Infect Dis (1996) 1.54
Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response. Infect Immun (1990) 1.51
Diagnosis of chronic Pseudomonas aeruginosa infection in cystic fibrosis by enzyme-linked immunosorbent assay. J Clin Microbiol (1987) 1.49
Simple, rapid latex agglutination test for serotyping of pneumococci (Pneumotest-Latex). J Clin Microbiol (2004) 1.49
In vivo pathogenicity of eight medically relevant Candida species in an animal model. Infection (2002) 1.48
Risk factors for hospital-acquired Staphylococcus aureus bacteremia. Arch Intern Med (1999) 1.48
Nosocomial pneumonia in an intensive care unit in a Danish university hospital: incidence, mortality and etiology. Scand J Infect Dis (1992) 1.46
Evaluation of Statens Serum Institut enteric medium for detection of enteric pathogens. J Clin Microbiol (1999) 1.45
Coagulase and protein A polymorphisms do not contribute to persistence of nasal colonisation by Staphylococcus aureus. J Med Microbiol (1997) 1.40
Immunoglobulin G antibodies to Helicobacter pylori in patients with dyspeptic symptoms investigated by the western immunoblot technique. J Clin Microbiol (1992) 1.39
Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin. Antimicrob Agents Chemother (1995) 1.37
Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch Intern Med (1999) 1.36
Susceptibility of Danish Escherichia coli strains isolated from urinary tract infections and bacteraemia, and distribution of sul genes conferring sulphonamide resistance. J Antimicrob Chemother (2002) 1.35
[Treatment of upper respiratory tract infections]. Ugeskr Laeger (2000) 1.31
In vitro antimicrobial susceptibility of Aerococcus urinae to 14 antibiotics, and time-kill curves for penicillin, gentamicin and vancomycin. J Antimicrob Chemother (2001) 1.29
Evaluation of cefoxitin 5 and 10 microg discs for the detection of methicillin resistance in staphylococci. J Antimicrob Chemother (2005) 1.28
Purification, characterization, and immunological cross-reactivity of alginates produced by mucoid Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol (1989) 1.28
Bacteremic Staphylococcus aureus spondylitis. Arch Intern Med (1998) 1.28
Evaluation of a new 3-h hybridization method for detecting the mecA gene in Staphylococcus aureus and comparison with existing genotypic and phenotypic susceptibility testing methods. J Antimicrob Chemother (1999) 1.24
Antimicrobial susceptibility testing of 230 Helicobacter pylori strains: importance of medium, inoculum, and incubation time. Antimicrob Agents Chemother (1997) 1.21
Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits. Antimicrob Agents Chemother (1998) 1.19
Interactions between Yersinia enterocolitica and rabbit ileal mucus: growth, adhesion, penetration, and subsequent changes in surface hydrophobicity and ability to adhere to ileal brush border membrane vesicles. Infect Immun (1991) 1.18
Quantitative immunoelectrophoretic analysis of Salmonella typhi antigens and of corresponding antibodies in human sera. Acta Pathol Microbiol Scand B (1980) 1.15
Genome-wide identification of Streptococcus pneumoniae genes essential for bacterial replication during experimental meningitis. Infect Immun (2010) 1.14
Isolation of Staphylococcus aureus clumping factor. Infect Immun (1985) 1.14
Clumping of Staphylococcus aureus by human fibronectin. Acta Pathol Microbiol Scand B (1981) 1.14
Hospital-acquired infections in a burns unit caused by an imported strain of Staphylococcus aureus with unusual multi-resistance. J Hyg (Lond) (1982) 1.10
Intracellular persistence of Escherichia coli in urinary bladders from mecillinam-treated mice. J Antimicrob Chemother (2005) 1.09
Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis. J Clin Microbiol (1990) 1.08
Chronic Pseudomonas aeruginosa lung infection in normal and athymic rats. APMIS (1993) 1.08
Isolation and preliminary evaluation of a low-molecular-mass antigen preparation for improved detection of Helicobacter pylori immunoglobulin G antibodies. Clin Diagn Lab Immunol (1995) 1.08
Role of the Yersinia outer membrane protein YadA in adhesion to rabbit intestinal tissue and rabbit intestinal brush border membrane vesicles. APMIS (1991) 1.07
Correlation of MIC methods and tentative interpretive criteria for disk diffusion susceptibility testing using NCCLS methodology for fusidic acid. Diagn Microbiol Infect Dis (2001) 1.07
Penicillin pharmacodynamics in four experimental pneumococcal infection models. Antimicrob Agents Chemother (2001) 1.07
Immunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection. Infect Immun (1994) 1.07
Activities of vancomycin and teicoplanin against penicillin-resistant pneumococci in vitro and in vivo and correlation to pharmacokinetic parameters in the mouse peritonitis model. Antimicrob Agents Chemother (1997) 1.06
[Daily single-dose aminoglycoside administration. Therapeutic and economic benefits]. Ugeskr Laeger (1993) 1.06
Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection. Antimicrob Agents Chemother (2000) 1.05
IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic Ps. aeruginosa infection investigated by ELISA. Clin Exp Immunol (1990) 1.04
Stomatococcus mucilaginosus endocarditis. Eur J Clin Microbiol (1985) 1.04
Interaction between limulus amoebocyte lysate and soluble antigens from Pseudomonas aeruginosa and Staphylococcus aureus studied by quantitative immunoelectrophoresis. J Clin Microbiol (1985) 1.03
Is Escherichia coli urinary tract infection a zoonosis? Proof of direct link with production animals and meat. Eur J Clin Microbiol Infect Dis (2011) 1.03
Evaluation of methods for the detection of nasal carriage of Staphylococcus aureus. APMIS (1994) 1.02
Bacterial histamine release by immunological and non-immunological lectin-mediated reactions. Allergy (1984) 1.02
Pretreatment with granulocyte colony-stimulating factor attenuates the inflammatory response but not the bacterial load in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits. Infect Immun (1999) 1.00
The typing of Staphylococcus epidermidis by a lectin-binding assay. J Med Microbiol (1992) 1.00
Treatment of pleural empyema secondary to pneumonia: thoracocentesis regimen versus tube drainage. Thorax (1992) 0.99
Changing pattern of bone and joint infections due to Staphylococcus aureus: study of cases of bacteremia in Denmark, 1959-1988. Rev Infect Dis (1991) 0.98
Microbial status and product labelling of 58 original tattoo inks. J Eur Acad Dermatol Venereol (2011) 0.98
Staphylococcus aureus carriage and infections among patients in four haemo- and peritoneal-dialysis centres in Denmark. The Danish Study Group of Peritonitis in Dialysis (DASPID). J Hosp Infect (1996) 0.98
Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: results from a prospective, randomized trial. Crit Care Med (1996) 0.98
First detection of plasmid-mediated quinolone resistance (qnrA and qnrS) in Escherichia coli strains isolated from humans in Scandinavia. J Antimicrob Chemother (2007) 0.97
Solid-phase radioimmunoassay of immunoglobulin G antibodies to Staphylococcus aureus peptidoglycan in patients with staphylococcal infections. Acta Pathol Microbiol Immunol Scand B (1983) 0.97
Comparison of Etest and a tablet diffusion test with the NCCLS broth microdilution method for fluconazole and amphotericin B susceptibility testing of Candida isolates. J Antimicrob Chemother (2001) 0.97
Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo. Antimicrob Agents Chemother (1998) 0.96
Antimicrobial resistance in Salmonella enterica subsp. enterica serovar typhimurium from humans and production animals. J Antimicrob Chemother (1997) 0.96
Antibiotic treatment insufficient for established septic arthritis. Staphylococcus aureus experiments in rabbits. Acta Orthop Scand (1989) 0.96
The pneumococcus and the mouse protection test: importance of the lag phase in vivo. Chemotherapy (1983) 0.95
Neurologic manifestations in Staphylococcus aureus endocarditis: a review of 260 bacteremic cases in nondrug addicts. Am J Med (1997) 0.95
Serological assays against Staphylococcus aureus peptidoglycan, crude staphylococcal antigen and staphylolysin in the diagnosis of serious S. aureus infections. Scand J Infect Dis (1985) 0.93
Evaluation of calibrated 1 and 10 microl loops and dipslide as compared to pipettes for detection of low count bacteriuria in vitro. APMIS (2001) 0.93
Inhibition of leukocyte entry into the brain by the selectin blocker fucoidin decreases interleukin-1 (IL-1) levels but increases IL-8 levels in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits. Infect Immun (2000) 0.92
Nosocomial outbreak of group C meningococcal disease. BMJ (1989) 0.92
Cross-reactions between Salmonella typhi and 24 other bacterial species. Acta Pathol Microbiol Scand B (1980) 0.92
Antibiotic usage in an intensive care unit in a Danish university hospital. J Antimicrob Chemother (1993) 0.91
Cross-reactions between Staphylococcus epidermidis and 23 other bacterial species. Acta Pathol Microbiol Scand B (1981) 0.91